EIGR

Eiger BioPharmaceuticals, Inc.

Delisted

EIGR was delisted on the 10th of April, 2024.

94 hedge funds and large institutions have $207M invested in Eiger BioPharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 34 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.56M
Puts
$1.25M
Net Calls
Net Calls Change

Top Sellers

1 -$1.7M
2 -$1.45M
3 -$963K
4
UBS Group
UBS Group
Switzerland
-$775K
5
Squarepoint
Squarepoint
New York
-$681K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$266K
52
$236K
53
$235K
54
$235K
55
$234K
56
$209K
57
$189K
58
$187K
59
$171K
60
$167K
61
$166K
62
$165K
63
$151K
64
$146K
65
$138K
66
$136K
67
$135K
68
$123K
69
$120K
70
$112K
71
$104K
72
$97K
73
$72K
74
$39K
75
$37K